Biological and chemical approaches to diseases of proteostasis deficiency

ET Powers, RI Morimoto, A Dillin… - Annual review of …, 2009 - annualreviews.org
Many diseases appear to be caused by the misregulation of protein maintenance. Such
diseases of protein homeostasis, or “proteostasis,” include loss-of-function diseases (cystic …

Proteostasis failure in neurodegenerative diseases: focus on oxidative stress

A Höhn, A Tramutola, R Cascella - Oxidative medicine and …, 2020 - Wiley Online Library
Protein homeostasis or proteostasis is an essential balance of cellular protein levels
mediated through an extensive network of biochemical pathways that regulate different …

HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?

C Simões-Pires, V Zwick, A Nurisso, E Schenker… - Molecular …, 2013 - Springer
Histone deacetylase (HDAC) inhibitors have been demonstrated to be beneficial in animal
models of neurodegenerative diseases. Such results were mainly associated with the …

[HTML][HTML] Emerging pathways to neurodegeneration: Dissecting the critical molecular mechanisms in Alzheimer's disease, Parkinson's disease

SH Tan, V Karri, NWR Tay, KH Chang, HY Ah… - Biomedicine & …, 2019 - Elsevier
Neurodegenerative diseases are usually sporadic in nature and commonly influenced by a
wide range of genetic, life style and environmental factors. A unifying feature of Alzheimer's …

Oxidative stress and neuroinflammation in the story of Parkinson's disease: could targeting these pathways write a good ending?

K Hassanzadeh, A Rahimmi - Journal of cellular physiology, 2019 - Wiley Online Library
Although, current medications for Parkinson's disease can control and relief symptoms of the
disease efficiently, they are unable to either prevent progression of the disease or maintain …

Aβ-mediated NMDA receptor endocytosis in Alzheimer's disease involves ubiquitination of the tyrosine phosphatase STEP61

P Kurup, Y Zhang, J Xu, DV Venkitaramani… - Journal of …, 2010 - Soc Neuroscience
Amyloid β (Aβ) is involved in the etiology of Alzheimer's disease (AD) and may contribute to
cognitive deficits by increasing internalization of ionotropic glutamate receptors. Striatal …

Potential pathways of abnormal tau and α-synuclein dissemination in sporadic Alzheimer's and Parkinson's diseases

H Braak, K Del Tredici - Cold Spring Harbor perspectives …, 2016 - cshperspectives.cshlp.org
Experimental data indicate that transneuronal propagation of abnormal protein aggregates
in neurodegenerative proteinopathies, such as sporadic Alzheimer's disease (AD) and …

Dietary plant polyphenols as the potential drugs in neurodegenerative diseases: current evidence, advances, and opportunities

L Yan, MS Guo, Y Zhang, L Yu, JM Wu… - Oxidative Medicine …, 2022 - Wiley Online Library
Neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD),
and Huntington's disease (HD), are characterized by the progressive degeneration of …

[HTML][HTML] Immunotherapy for Parkinson's disease

AD Schwab, MJ Thurston, J Machhi, KE Olson… - Neurobiology of …, 2020 - Elsevier
With the increasing prevalence of Parkinson's disease (PD), there is an immediate need to
interdict disease signs and symptoms. In recent years this need was met through therapeutic …

Phosphorylation modulates clearance of alpha-synuclein inclusions in a yeast model of Parkinson's disease

S Tenreiro, MM Reimao-Pinto, P Antas, J Rino… - PLoS …, 2014 - journals.plos.org
Alpha-synuclein (aSyn) is the main component of proteinaceous inclusions known as Lewy
bodies (LBs), the typical pathological hallmark of Parkinson's disease (PD) and other …